This coming week is a busy one for Initial Public Offerings. In order of largest IPO first:
(1) Based in Chesterland, Ohio, FMSA Holdings (FMSA) scheduled a $1 billion IPO with a market capitalization of $2.736 billion on the NYSE at a price range midpoint of $22.50 for Friday, October 3, 2014.
Fairmount Santrol (FMSA) is one of the world’s largest providers of sand-based proppant solutions and for over 30 years has been a pioneer in the development of high performance proppants used by oilfield service and E&P companies to enhance the productivity of their oil and gas wells.
(2) Based in Radnor, PA,VWR Corp. (VWR) scheduled a $600 million IPO on NASDAQ with a market capitalization of $3 billion at a price range midpoint of $23.50 for the week of September 29, 2014.
VWR is a leading, independent provider of laboratory products, services and solutions to the global life science, general research and applied markets.
(3) Based in Provo, Utah,Vivint Solar (VSLR) scheduled a $350 million IPO on NYSE with a market capitalization of $1.8 billion at a price range midpoint of $17 for Thursday, Oct. 2, 2014.
VSLR offers distributed solar energy — electricity generated by a solar energy system installed at or near customers’ locations — to residential customers based on 20-year contracts at prices below their current utility rates.
(4) Based in Madrid, Spain, Atento S.A. (ATTO) scheduled a $300 million IPO on NYSE with a market capitalization of $1.5 billion at a price range midpoint of $20.50 for Thursday, Oct. 2, 2014.
ATTO is the largest provider of CRM BPO services in Latin America and Spain, and among the top three providers globally, based on revenues. (CRM BPO = customer relationship management and business process outsourcing.)
(5) Based in Boston, MA, Wayfair (W) scheduled a $292 million IPO on NYSE with a market capitalization of $2.2 billion at a price range midpoint of $26.50 for Thursday, Oct. 2, 2014.
Through its e-commerce business model, W offers visually inspiring browsing, compelling merchandising, easy product discovery and attractive prices for over seven million products from over 7,000 suppliers across its five distinct brands: Wayfair.com, Joss & Main, AllModern, DwellStudio and Birch Lane.
(6) Based in Irving, Texas, JP Energy Partners LP (JPEP) scheduled a $276 million IPO at a price range midpoint of $20 on the NYSE with a market capitalization of $728 million for Thursday, October 2, 2014.
JPEP is a growth-oriented limited partnership formed in May 2010 by members of management and further capitalized in June 2011 by ArcLight to own, operate, develop and acquire a diversified portfolio of midstream energy assets.
(7) Based in South San Francisco,Calithera Biosciences (CALA) scheduled an $84 million IPO on NASDAQ with a market capitalization of $223 million at a price range midpoint of $14 for Thursday, Oct. 2, 2014.
CALA is currently conducting three Phase 1 clinical trials of CB-839 in the United States in patients with solid tumors, leukemias, lymphomas and multiple myeloma.
(8) Based in Redwood City, CA, Dermira (DERM) scheduled an $81 million IPO on NASDAQ with a market capitalization of $254 million at a price midpoint of $15, for Friday, October 3, 2014.
DERM is a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products to dermatologists and their patients.
(9) Based in Redwood City, CA, Yodlee (YDLE) scheduled a $75 million IPO on NASDAQ with a market capitalization of $340 million at a price range midpoint of $12 for Friday, October 3, 2014.
Yodlee is a leading technology and applications platform powering dynamic innovation for digital financial services in the cloud.
(10) Based in Brentwood, TN, AAC Holdings (ACC) scheduled a $65 million IPO on the NYSE with a market capitalization of $269 million at a price range midpoint of $13 for Thursday, October 2, 2014
ACC believes it is a leading provider of inpatient substance abuse treatment services for individuals with drug and alcohol addiction.
(11) Based in Waltham, MA, EyeGate Pharmaceuticals (EYEG) scheduled a $25 million IPO on NASDAQ with a market capitalization of $92 million at a price range midpoint of $13 for Friday, October 3, 2014.
EYEG is a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye.
Full IPO calendar and reports here.
Disclaimer: This report is based on independent analysis by IPOdesktop.com. There are no unattributed direct quotes in this article.